Vizzhy provides a precision cardiology platform that reconstructs a patient’s “BioTwin” by integrating multi‑omics data, imaging, sensor streams, and clinical records to reveal the underlying biological drivers of cardiovascular risk. The physician‑facing interface translates these insights into actionable treatment plans, including drug safety assessments, care sequencing, nutrition, and exercise guidance, enabling clinicians to intervene before events occur. The system plugs into existing cardiology workflows without requiring EMR replacement.
Funding
Funding not disclosed
Founders
Product
Problem
Cardiology practice typically reacts to overt events such as blockages or heart attacks, while the underlying biological drivers of cardiovascular disease develop long before they are detectable by standard labs, imaging, or clinical markers. This early-stage information gap limits physicians’ ability to intervene proactively and to select therapies that address the root mechanisms of a patient’s risk.
Solution
Vizzhy offers a physician‑facing platform that reconstructs a patient’s multi‑omics profile into a computed “BioTwin,” a comprehensive model of current biology across genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics, microbiome, imaging, sensor data, and clinical records. The system cross‑layer analyzes these data to identify concordant and discordant signals, scoring health dimensions such as inflammation, vascular integrity, metabolic reserve, mitochondrial function, and coagulation balance. By revealing the upstream mechanisms driving cardiovascular risk, Vizzhy delivers actionable precision recommendations for drugs, nutrition, exercise, and care sequencing, enabling clinicians to intervene before clinical events occur. The platform integrates into existing cardiology workflows via a dedicated clinical intelligence console, without requiring EMR replacement, and supports continuous monitoring through sensor integration.
Target Audience
Primary users are cardiologists, cardiovascular specialists, and hospital cardiology programs seeking to implement mechanism‑based preventive care and precision treatment pathways for patients at risk of cardiovascular disease.
Features
- Multi‑omics sample collection and laboratory analysis covering genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics, microbiome, and clinical data
- Cross‑layer terrain computation that scores multiple health dimensions and highlights agreements or contradictions among biological layers
- Physician‑facing clinical cognition interface presenting the BioTwin, cross‑layer findings, treatment readiness, and trajectory visualizations
- Precision drug assessment layer with genomic safety gates and pathway compatibility analysis
- Care sequencing module that orders interventions from upstream mechanisms to downstream treatments, including safety pacing
- Nutrition and exercise guidance customized to patient‑specific biological constraints and safety limits
- Continuous sensor monitoring with real‑time alerts and early‑warning signals integrated into the platform
- Imaging integration that maps structural findings to biological terrain for coherent disease interpretation